Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q9GZV9 (FGF23_HUMAN)

Last modified June 16, 2009. Version 95. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Fibroblast growth factor 23
      Short name=FGF-23
Alternative name(s):
    Tumor-derived hypophosphatemia-inducing factor
    Phosphatonin
Cleaved into the following 2 chains:
    1- Recommended name:
            Fibroblast growth factor 23 N-terminal peptide
    2- Recommended name:
            Fibroblast growth factor 23 C-terminal peptide
Gene names
Name: FGF23
Synonyms: HYPF
ORF Names: UNQ3027/PRO9828
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length251 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Subcellular location

Secreted.

Post-translational modification

After secretion it is processed into a N-terminal fragment and a C-terminal fragment. The processing is effected by the proprotein convertases.

Involvement in disease

Defects in FGF23 are the cause of autosomal dominant hypophosphataemic rickets (ADHR) [MIM:193100]. ADHR is characterized by low serum phosphorus concentrations, rickets, osteomalacia, leg deformities, short stature, bone pain and dental abscesses. Ref.2

Defects in FGF23 are a cause of hyperphosphatemic familial tumoral calcinosis (HFTC) [MIM:211900]. HFTC is a severe autosomal recessive metabolic disorder that manifests with hyperphosphatemia and massive calcium deposits in the skin and subcutaneous tissues. Ref.12

Sequence similarities

Belongs to the heparin-binding growth factors family.

Ontologies

Keywords
   Cellular componentSecreted
   Coding sequence diversityPolymorphism
   DiseaseDisease mutation
   DomainSignal
   Molecular functionGrowth factor
   PTMDisulfide bond
   Technical term3D-structure
Direct protein sequencing
Gene Ontology (GO)
   Biological processcell differentiation

Non-traceable author statement. Source: UniProtKB

fibroblast growth factor receptor signaling pathway

Inferred from Experiment. Source: Reactome

   Cellular componentextracellular space

Non-traceable author statement. Source: UniProtKB

   Molecular functiongrowth factor activity

Inferred from electronic annotation. Source: UniProtKB-KW

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 2424 Ref.7
Chain25 – 251227Fibroblast growth factor 23
PRO_0000008998
Chain25 – 179155Fibroblast growth factor 23 N-terminal peptide
PRO_0000352875
Chain180 – 25172Fibroblast growth factor 23 C-terminal peptide
PRO_0000352876

Sites

Site179 – 1802Cleavage; by proprotein convertases

Amino acid modifications

Disulfide bond95 ↔ 113

Natural variations

Natural variant711S → G in HFTC; only the C-terminal fragment is secreted, whereas the intact protein is retained in the Golgi complex. Ref.12
VAR_023831
Natural variant1761R → Q in ADHR. Ref.2
VAR_010717
Natural variant1791R → Q in ADHR; C-terminal processing is abolished. Ref.2
VAR_010719
Natural variant1791R → W in ADHR; C-terminal processing is abolished. Ref.2
VAR_010718
Natural variant1951P → S: dbSNP rs13312793. Ref.5
VAR_018887
Natural variant2391T → M: dbSNP rs7955866. Ref.2 Ref.5
VAR_010720

Secondary structure

.................................... 251
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Q9GZV9-1 [UniParc].

Last modified March 1, 2001. Version 1.
Checksum: 6093BD0CC50C2489

FASTA25127,954
        10         20         30         40         50         60 
MLGARLRLWV CALCSVCSMS VLRAYPNASP LLGSSWGGLI HLYTATARNS YHLQIHKNGH 

        70         80         90        100        110        120 
VDGAPHQTIY SALMIRSEDA GFVVITGVMS RRYLCMDFRG NIFGSHYFDP ENCRFQHQTL 

       130        140        150        160        170        180 
ENGYDVYHSP QYHFLVSLGR AKRAFLPGMN PPPYSQFLSR RNEIPLIHFN TPIPRRHTRS 

       190        200        210        220        230        240 
AEDDSERDPL NVLKPRARMT PAPASCSQEL PSAEDNSPMA SDPLGVVRGG RVNTHAGGTG 

       250 
PEGCRPFAKF I 

« Hide

References

« Hide 'large scale' references
[1]"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain."
Yamashita T., Yoshioka M., Itoh N.
Biochem. Biophys. Res. Commun. 277:494-498(2000) [PubMed: 11032749] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[2]"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23."
White K.E., Evans W.E., O'Riordan J.L.H., Speer M.C., Econs M.J., Lorenz-Depiereux B., Grabowski M., Meitinger T., Strom T.M.
Nat. Genet. 26:345-348(2000) [PubMed: 11062477] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ADHR GLN-176; GLN-179 AND TRP-179, VARIANT MET-239.
[3]"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia."
Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., Takeuchi Y., Fujita T., Fukumoto S., Yamashita T.
Proc. Natl. Acad. Sci. U.S.A. 98:6500-6505(2001) [PubMed: 11344269] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[4]"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment."
Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. expand/collapse author list , Heldens S., Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.
Genome Res. 13:2265-2270(2003) [PubMed: 12975309] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[5]NIEHS SNPs program
Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS SER-195 AND MET-239.
[6]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[7]"Signal peptide prediction based on analysis of experimentally verified cleavage sites."
Zhang Z., Henzel W.J.
Protein Sci. 13:2819-2824(2004) [PubMed: 15340161] [Abstract]
Cited for: PROTEIN SEQUENCE OF 25-39.
[8]"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting."
White K.E., Jonsson K.B., Carn G., Hampson G., Spector T.D., Mannstadt M., Lorenz-Depiereux B., Miyauchi A., Yang I.M., Ljunggren O., Meitinger T., Strom T.M., Jueppner H., Econs M.J.
J. Clin. Endocrinol. Metab. 86:497-500(2001) [PubMed: 11157998] [Abstract]
Cited for: PROCESSING.
[9]"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo."
Shimada T., Muto T., Urakawa I., Yoneya T., Yamazaki Y., Okawa K., Takeuchi Y., Fujita T., Fukumoto S., Yamashita T.
Endocrinology 143:3179-3182(2002) [PubMed: 12130585] [Abstract]
Cited for: PROCESSING.
[10]"FGF23 is processed by proprotein convertases but not by PHEX."
Benet-Pages A., Lorenz-Depiereux B., Zischka H., White K.E., Econs M.J., Strom T.M.
Bone 35:455-462(2004) [PubMed: 15268897] [Abstract]
Cited for: PROCESSING BY PROPROTEIN CONVERTASES.
[11]"Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members."
Goetz R., Beenken A., Ibrahimi O.A., Kalinina J., Olsen S.K., Eliseenkova A.V., Xu C., Neubert T.A., Zhang F., Linhardt R.J., Yu X., White K.E., Inagaki T., Kliewer S.A., Yamamoto M., Kurosu H., Ogawa Y., Kuro-o M. expand/collapse author list , Lanske B., Razzaque M.S., Mohammadi M.
Mol. Cell. Biol. 27:3417-3428(2007) [PubMed: 17339340] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 25-179.
[12]"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia."
Benet-Pages A., Orlik P., Strom T.M., Lorenz-Depiereux B.
Hum. Mol. Genet. 14:385-390(2005) [PubMed: 15590700] [Abstract]
Cited for: VARIANT HFTC GLY-71.
+Additional computationally mapped references.

Cross-references

Sequence databases

AB037973 mRNA. Translation: BAB13477.1.
AF263537 mRNA. Translation: AAG09917.1.
AB047858 mRNA. Translation: BAB55889.1.
AY358323 mRNA. Translation: AAQ88689.1.
AY566236 Genomic DNA. Translation: AAS59157.1.
BC069333 mRNA. Translation: AAH69333.1.
BC096713 mRNA. Translation: AAH96713.1.
BC098147 mRNA. Translation: AAH98147.1.
BC098252 mRNA. Translation: AAH98252.1.
IPIIPI00026407.
RefSeqNP_065689.1.
UniGeneHs.287370

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
2P39X-ray1.50A25-179[»]
ModBaseSearch...

Proteomic databases

PRIDEQ9GZV9.

Genome annotation databases

EnsemblENSG00000118972. Homo sapiens. [Contig view]
GeneID8074.
KEGGhsa:8074.
NMPDRfig|9606.3.peg.6984.

Organism-specific databases

GeneCardsGC12M004347.
H-InvDBHIX0036668.
HGNCHGNC:3680. FGF23.
MIM193100. phenotype.
211900. phenotype.
605380. gene.
Orphanet53715. Calcinosis, tumoral.
437. Vitamin D resistant rickets.
PharmGKBPA28119.
GenAtlasSearch...

Phylogenomic databases

HOGENOMQ9GZV9.
HOVERGENQ9GZV9.
OMAQ9GZV9. ASDPLGV.

Enzyme and pathway databases

Pathway_Interaction_DBfgf_pathway. FGF signaling pathway.
ReactomeREACT_9470. Signaling by FGFR.

Gene expression databases

ArrayExpressQ9GZV9.
BgeeQ9GZV9.
CleanExHS_FGF23.
GermOnlineENSG00000118972. Homo sapiens.

Family and domain databases

InterProIPR002348. IL1_HBGF.
[Graphical view]
PANTHERPTHR11486. IL1_HBGF. 1 hit.
PfamPF00167. FGF. 1 hit.
[Graphical view]
PRINTSPR00262. IL1HBGF.
ProDomPD000831. IL1_HBGF. 1 hit.
[Graphical view] [Entries sharing at least one domain]
SMARTSM00442. FGF. 1 hit.
[Graphical view]
PROSITEPS00247. HBGF_FGF. False negative.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio30678.
SOURCESearch...

Entry information

Entry nameFGF23_HUMAN
AccessionPrimary (citable) accession number: Q9GZV9
Secondary accession number(s): Q4V758
Entry history
Integrated into UniProtKB/Swiss-Prot: April 27, 2001
Last sequence update: March 1, 2001
Last modified: June 16, 2009
This is version 95 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 12

Human chromosome 12: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents